Bristol Myers Squibb
Global biopharmaceutical company deploying enterprise AI across its operations while partnering with AI-native discovery companies on molecular design.
- Company type
- Global biopharmaceutical company
- Headquarters
- Princeton, United States
- Website
- https://www.bms.com
- Profile last verified
- 2026-07-29
AI Partnerships & Deployments
- 2026-05-20 — Strategic enterprise agreement with Anthropic (Claude Enterprise) (Anthropic (Claude Enterprise)). Bristol Myers Squibb announced a strategic agreement with Anthropic to deploy Claude across research, clinical development, regulatory, manufacturing, and commercial functions. Coverage reported the rollout spanning roughly 30,000 employees. Source: MobiHealthNews (accessed 2026-07-29)
- 2024-02-13 — Molecular-glue drug discovery collaboration with VantAI (VantAI). Bristol Myers Squibb entered a collaboration with VantAI to accelerate the discovery of molecular-glue degraders using AI-driven structural prediction. Financial terms were disclosed in the companies' release. Source: Business Wire (VantAI release) (accessed 2026-07-29)